Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 9/20 | 0.45 |
| ▸ | CA2 | P00918 | 9/20 | 0.45 |
| ▸ | GSK3B | P49841 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 3/20 | 0.41 |
| ▸ | CA9 | Q16790 | 3/20 | 0.41 |
| ▸ | GRK6 | P43250 | 2/20 | 0.41 |
| ▸ | ADK | P55263 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8711595 | 1.00 | TSHR (0.46) | TSHRCA1CA2GSK3BNPC1 | |
| SCHEMBL788634 | 1.00 | TSHR (0.46) | TSHRCA1CA2GSK3BNPC1 | |
| SCHEMBL375915 | 1.00 | TSHR (0.46) | TSHRCA1CA2GSK3BNPC1 | |
| SCHEMBL7030562 | 1.00 | TSHR (0.46) | TSHRCA1CA2GSK3BNPC1 | |
| SCHEMBL38256 | 1.00 | TSHR (0.46) | TSHRCA1CA2GSK3BNPC1 | |
| SCHEMBL7198908 | 1.00 | TSHR (0.46) | TSHRCA1CA2GSK3BNPC1 | |
| SCHEMBL4278638 | 1.00 | TSHR (0.46) | TSHRCA1CA2GSK3BNPC1 | |
| SCHEMBL319584 | 1.00 | TSHR (0.46) | TSHRCA1CA2GSK3BNPC1 | |
| SCHEMBL4704343 | 1.00 | TSHR (0.46) | TSHRCA1CA2GSK3BNPC1 | |
| SCHEMBL7528649 | 0.99 | TSHR (0.48) | TSHRCA1CA2GSK3BNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0048022-A2 | Enhancer of anti-tumor effect | Yamasa Shoyu Kabushiki Kaisha (JP) | 1982-03-24 | — | — | EP | disclosed |